tiprankstipranks
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
PremiumStock Analysis & IdeasCRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
19d ago
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
PremiumStock Analysis & Ideas
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
1M ago
bluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
PremiumClass Action
bluebird bio, Inc. Class Action: Levi & Korsinsky LLP Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 – BLUE
1M ago
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
PremiumThe FlyBluebird Bio price target lowered to $1.68 from $3 at Wedbush
2M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
2M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
2M ago
Bluebird Bio 83.33M share Secondary priced at $1.50
PremiumThe FlyBluebird Bio 83.33M share Secondary priced at $1.50
5M ago
Bluebird Bio 8.333M share Secondary priced at $1.50
PremiumThe Fly
Bluebird Bio 8.333M share Secondary priced at $1.50
5M ago
Bluebird Bio price target lowered to $5 from $7 at Morgan Stanley
PremiumThe Fly
Bluebird Bio price target lowered to $5 from $7 at Morgan Stanley
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100